7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes

Biochemical Pharmacology

Volumn 51, Issue 3, 1996, Pages 313-319

  Yamazaki, Hiroshi ^a   Inoue, Kiyoshi ^a   Mimura, Mayumi ^a   Oda, Yoshimitsu ^a   Guengerich, F Peter ^b   Shimada, Tsutomu ^a  

^a OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

7 ethoxycoumarin; human P450; kinetic analysis; P450 1A2; P450 2E1

Indexed keywords

7 ETHOXYCOUMARIN DEETHYLASE; CYTOCHROME P450 ISOENZYME; ENZYME ANTIBODY; RECOMBINANT ENZYME; RECOMBINANT PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME KINETICS; ENZYME PURIFICATION; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER MICROSOME METABOLISM; LYMPHOBLASTOID CELL; PRIORITY JOURNAL;

EID: 0030064194     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02178-7     Document Type: Article

References (46)

1. Guengerich FP and Shimada T, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4: 391-407, 1991.
2. Guengerich FP, Characterization of human microsomal cytochrome P-450 enzymes. Annu Rev Pharmacol Toxicol 29: 241-264, 1989.
3. Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP and Yang CS, Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 6: 511-518, 1993.
4. Yasumori T, Nagata K, Yang SK, Chen LS, Murayama N, Yamazoe Y and Kato R, Cytochrome P450 mediated metabolism of diazepam in human and rat: Involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics 3: 291-301, 1993.
5. Yamazaki H, Guo Z, Persmark M, Mimura M, Inoue K, Guengerich FP and Shimada T, Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Mol Pharmacol 46: 568-577, 1994.
6. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270: 414-423, 1994.
7. Yamazaki H, Mimura M, Oda Y, Inui Y, Shiraga T, Iwasaki K, Guengerich FP and Shimada T, Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes. Carcinogenesis 14: 1271-1278, 1993.
8. Greenlee WF and Poland A, An improved assay of 7-ethoxycoumarin O-deethylation activity: Induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Pharmacol Exp Ther 205: 596-605, 1978.
9. Ryan DE and Levin W, Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol Ther 45: 153-239, 1990.
10. Wrighton SA, Vandenbranden M, Becker GW, Black SD and Thomas PE, Two monoclonal antibodies recognizing different epitopes on rat cytochrome IIB1 react with human IIE1. Mol Pharmacol 41: 76-82, 1992.
11. Wrighton SA and Stevens JC, The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 22: 1-21, 1992.
12. Mimura M, Baba T, Yamazaki H, Ohmori S, Inui Y, Gonzalez FJ, Guengerich FP and Shimada T, Characterization of cytochrome P450 2B6 in human liver microsomes. Drug Metab Dispos 21: 1048-1056, 1993.
13. Guengerich FP, Analysis and characterization of enzymes. In: Principles and Methods of Toxicology (Ed. Hayes AW), 3rd Edn, pp. 1259-1313. Raven Press, New York, 1994.
14. Yun C-H, Shimada T and Guengerich FP, Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol 40: 679-685, 1991.
15. Guengerich FP, Kim DH and Iwasaki M, Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4: 168-179, 1991.
16. Guo Z, Gillam EMJ, Ohmori S, Tukey RH and Guengerich FP, Expression of modified human cytochrome P450 1A1 in Escherichia coli: Effects of 5′ substitution, stabilization, purification, spectral characterization, and catalytic properties. Arch Biochem Biophys 312: 436-446, 1994.
17. Sandhu P, Guo Z, Baba T, Martin MV, Tukey RH and Guengerich FP, Expression of modified human cytochrome P450 1A2 in Escherichia coli. Stabilization, purification, spectral characterization, and catalytic activities of the enzymes. Arch Biochem Biophys 309: 168-177, 1994.
18. Sandhu P, Baba T and Guengerich FP, Expression of modified human cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch Biochem Biophys 306: 443-450, 1993.
19. Gillam EMJ, Guo Z, Martin MV, Jenkins CM and Guengerich FP, Expression of cytochrome P450 2D6 in Escherichia coli, purification, and spectral and catalytic characterization. Arch Biochem Biophys 319: 540-550, 1995.
20. Gillam EMJ, Guo Z and Guengerich FP, Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch Biochem Biophys 312: 59-66, 1994.
21. Gillam EMJ, Baba T, Kim B-R, Ohmori S and Guengerich FP, Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch Biochem Biophys 305: 123-131, 1993.
22. Gillam EMJ, Guo Z, Ueng Y-F, Yamazaki H, Cock I, Reilly PEB, Hopper WD and Guengerich FP, Expression of cytochrome P450 3A5 in Escherichia coli: Effects of 5′ modification, purification, spectral characterization, reconstitution conditions, and catalytic activities. Arch Biochem Biophys 317: 374-384, 1995.
23. Kaminsky LS, Fasco MJ and Guengerich FP, Production and application of antibodies to rat liver cytochrome P-450. Methods Enzymol 74: 262-272, 1981.
24. Yasukochi Y and Masters B, Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J Biol Chem 251: 5337-5344, 1976.
25. Taniguchi H, Imai Y, Iyanagi T and Sato R, Interaction between NADPH-cytochrome P-450 reductase and cytochrome P-450 in the membrane of phosphatidylcholine vesicles. Biochim Biophys Acta 550: 341-356, 1979.
26. Shimada T and Nakamura S, Cytochrome P-450-mediated activation of procarcinogens and promutagens to DNA-damaging products by measuring expression of umu gene in Salmonella typhimurium TA1535/pSK1002. Biochem Pharmacol 36: 1979-1987, 1987.
27. Imaoka S, Imai Y, Shimada T and Funae Y, Role of phospholipids in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity. Biochemistry 31: 6063-6069, 1992.
28. Yamazaki H, Degawa M, Funae Y, Imaoka S, Inui Y, Guengerich FP and Shimada T, Roles of different cytochrome P-450 enzymes in bioactivation of the potent hepatocarcinogen 3-methoxy-4-aminoazobenzene by rat and human liver microsomes. Carcinogenesis 12: 133-139, 1991.
29. Omura T and Sato R, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239: 2370-2378, 1964.
30. Guengerich FP, Wang P and Davidson NK, Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry 21: 1698-1706, 1982.
31. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ, Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
32. Nash J, Conpact numerial methods for computers: Linear algebra and function minimization. Wiley, New York, 1979.
33. Peter R, Bocker R, Beaune PH, Iwasaki M, Guengerich FP and Yang CS, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450 IIE1. Chem Res Toxicol 3: 566-573, 1990.
34. Mimura M, Yamazaki H, Sugahara C, Hiroi T, Funae Y and Shimada T, Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes. Biochem Pharmacol 47: 1957-1963, 1994.
35. Shimada T, Iwasaki M, Martin MV and Guengerich FP, Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Res 49: 3218-3228, 1989.
36. Shimada T, Misono KS and Guengerich FP, Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J Biol Chem 261: 909-921, 1986.
37. Shimada T and Guengerich FP, Participation of a rat liver cytochrome P-450 induced by pregnenolone 16α-carbonitrile and other compounds in the 4-hydroxylation of mephenytoin. Mol Pharmacol 28: 215-219, 1985.
38. Goldstein JA, Faletto MB, Romkes-Sparks M, Sullivan T, Kitareewan S, Raucy JL, Lasker JM and Ghanayem BI, Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans. Biochemistry 33: 1743-1752, 1994.
39. 1 by bacterial recombinant human cytochrome P450 enzymes. Chem Res Toxicol 8: 218-225, 1995.
40. 1 by constitutive forms of cytochrome P-450 in rat liver microsomes. Toxicol Appl Pharmacol 91: 13-21, 1987.
41. NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc Natl Acad Sci USA 86: 462-465, 1989.
42. Boobis AR, Kahn GC, Whyte C, Brodie MJ and Davies DS, Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions. Biochem Pharmacol 30: 2451-2456, 1981.
43. Bayliss MK, Bell JA, Wilson K and Park GR, 7-Ethoxycoumarin O-deethylase kinetics in isolated rat, dog and human hepatocyte suspensions. Xenobiotica 24: 231-241, 1994.
44. Hunt CM, Watkins PB, Saenger P, Stave GM, Barlascini N, Watlington CO, Wright JT and Guzelian PS, Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol. Clin Pharmacol Ther 51: 18-23, 1992.
45. Watkins PB, Turgeon DK, Saenger P, Lown KS, Kolars JC, Hamilton T, Fishman K, Guzelian PS and Voorhees JJ, Comparison of urinary 6-β-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity. Clin Pharmacol Ther 52: 265-273, 1992.
46. Shimada T, Yun C-H, Yamazaki H, Gautier J-C, Beaune PH and Guengerich FP, Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol 41: 856-864, 1992.